Alzheimer’s 2030: From Precision Genomics to Artificial Intelligence
Genes · 12.02.2026 · 17 (2) · 233
DOI: 10.3390/genes17020233 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 12.02.2026. Verfasst von Valeria D'Argenio und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Sciences and Quality of Life Promotion, San Raffaele Open University, Via di Val Cannuta 247, 00166 Rome, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Artificial Intelligence, Genomics, Precision Medicine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ricerca Corrente anno 2025, Ministero della Salute.
Abstract (Originalsprache)
Alzheimer’s disease (AD) represents a critical global health challenge, with its prevalence and associated costs expected to double significantly by 2030 and 2050. While lifestyle interventions are crucial, sporadic late-onset AD has a substantial genetic component (40–80% heritability), though known variants limit the scope of traditional precision medicine. Crucially, sex and gender are significant risk determinants, with women accounting for two-thirds of cases due to a complex interplay of biological and sociocultural factors. This review focuses on the influence of genetic and gender-related factors, examining large-scale genome-wide association studies (GWASs) and their role in developing advanced genetic risk scores (GRS) for precision genomics. We also explore the potential of Artificial Intelligence (AI) for multimodal big data analysis and digital health tools to promote personalized prevention and emerging concerns about ethics, privacy and data treatment. The convergence of these findings underscores the urgent need for a genetic-, sex- and gender-informed precision-medicine approach to AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Human Sciences and Quality of Life Promotion, San Raffaele Open University, Via di Val Cannuta 247, 00166 Rome, Italy.
- CEINGE-Biotecnologie Avanzate Franco Salvatore, Via G. Salvatore 486, 80145 Naples, Italy.
- Università Vita-Salute San Raffaele, 20123 Milan, Italy.
- IRCCS Galeazzi Sant'Ambrogio, 20157 Milan, Italy.
- Unit of Clinical Epidemiology, IRCCS Istituto Ortopedico Galeazzi, 20157 Milan, Italy.
- Biobank and Clinical Neurochemistry, IRCCS Santa Lucia Foundation, 00179 Rome, Italy.
ORCID-Profile: Valeria D'Argenio, Silvia Bargeri, Giulia Sancesario
Förderung
- Ricerca Corrente anno 2025, Ministero della Salute
Zitieren
APA
D'Argenio, V., Tomaiuolo, R., Bargeri, S., & Sancesario, G. (2026). Alzheimer’s 2030: From Precision Genomics to Artificial Intelligence. Genes, 17(2), 233. https://doi.org/10.3390/genes17020233
Vancouver
D'Argenio V, Tomaiuolo R, Bargeri S, Sancesario G. Alzheimer’s 2030: From Precision Genomics to Artificial Intelligence. Genes. 2026;17(2):233. doi:10.3390/genes17020233
BibTeX
@article{DArgenio2026,
author = {D'Argenio, Valeria and Tomaiuolo, Rossella and Bargeri, Silvia and Sancesario, Giulia},
title = {Alzheimer’s 2030: From Precision Genomics to Artificial Intelligence},
journal = {Genes},
year = {2026},
volume = {17},
number = {2},
pages = {233},
doi = {10.3390/genes17020233}
}
EUVIMED